GILEAD SCIENCES, INC. Short-Term Debt 2011-2026 | GILD
Beta
What is short-term debt?
Short-term debt includes borrowings and the current portion of long-term debt due within one year.
What is GILEAD SCIENCES, INC.'s current short-term debt?
GILEAD SCIENCES, INC. (GILD) annual short-term debt for 2025 was $2.81B, a 54.66% increase from 2024. GILEAD SCIENCES, INC. short-term debt for the quarter ending March 31, 2026 was $1.31B.
What was GILEAD SCIENCES, INC.'s short-term debt in 2024?
GILEAD SCIENCES, INC. annual short-term debt for 2024 was $1.81B, a 0.95% increase from 2023.
What was GILEAD SCIENCES, INC.'s short-term debt in 2023?
GILEAD SCIENCES, INC. annual short-term debt for 2023 was $1.80B, a 20.90% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year short-term debt CAGR?
GILEAD SCIENCES, INC. short-term debt grew at a compound annual growth rate (CAGR) of 0.36% from FY2020 to FY2025, going from $2.76B to $2.81B over 5 years.
Short-Term Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.4%
FY2020
$2.76B
→
FY2025
$2.81B
111213141516171819202122232425
5 years selected
Short-Term Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.81B | +54.7% | 10-K |
| FY2024 | $1.81B | +0.9% | 10-K |
| FY2023 | $1.80B | -20.9% | 10-K |
| FY2022 | $2.27B | +49.9% | 10-K |
| FY2021 | $1.52B | -45.0% | 10-K |
| FY2020 | $2.76B | +10.3% | 10-K |
| FY2019 | $2.50B | -9.1% | 10-K |
| FY2018 | $2.75B | +0.0% | 10-K |
| FY2017 | $2.75B | - | 10-K |
| FY2016 | $0 | -100.0% | 10-K |
| FY2015 | $982.0M | +103.3% | 10-K |
| FY2014 | $483.0M | -82.1% | 10-K |
| FY2013 | $2.70B | +130.6% | 10-K |
| FY2012 | $1.17B | - | 10-K |
| FY2011 | $0 | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →